The potential risk of VTE is greatest during the first calendar year of utilization of a COC and when restarting hormonal contraception after a break of 4 months or for a longer period. The potential risk of thromboembolic disorder on account of COCs progressively disappears right after COC use is discontinued. Figure one reveals the chance of crea